ReT01 cell therapy for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new cell therapy called ReT01 for people with advanced solid tumors that have stopped responding to standard treatments. It uses your own immune cells from a tumor sample to fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have an advanced solid tumor (like certain lung, breast, cervical, ovarian, liver, head and neck, or colorectal cancer) that has failed standard therapy.
- You need to have a tumor sample taken that is large enough to make the therapy.
- You must have at least one other tumor that can be measured on scans after the sample is taken.
- Your overall health (ECOG score) should be 0 or 1, meaning you are fully active or only slightly limited.
- You must not have had certain other treatments like prior cell therapies or live vaccines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 1 trial tests a new way to use your own immune cells to fight advanced solid tumors. The treatment is given directly into the tumor. It is for people who have run out of standard treatment options.
This study tests a new treatment that takes immune cells from a small piece of your tumor, grows them in a lab, and then puts them back into your body to fight the cancer. It is for people with advanced lung, cervical, or breast cancer who have already tried standard treatments.
This trial tests an experimental treatment called GK01, which uses your own immune cells (called tumor-infiltrating lymphocytes) that have been taken from your tumor, multiplied in a lab, and given back to you. It is for people with advanced solid tumors that have not responded to standard treatments, and aims to see if these cells can shrink your cancer.
This study tests a personalized treatment made from your own immune cells (T cells) that are re-engineered to recognize and attack your specific tumor. It is for people with advanced solid tumors that have not responded to other treatments. If you qualify, you will have a blood draw and a tumor sample collected to create your own custom T cell therapy.
This trial tests a new therapy using your own immune cells, engineered to recognize and attack cancer cells. It is for people with advanced solid tumors who have no other standard treatment options.
This trial tests a personalized treatment that uses your own immune cells, modified to recognize and attack your cancer. It may help people with advanced solid tumors who have not improved with standard treatments.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.